Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Assil Gaur Eye Institute (AGEI) is a world-renowned ophthalmology practice and clinical research center based in Los Angeles, California. The institute specializes in advanced vision correction procedures, including LASIK, PRK, and premium lens implants for cataracts and presbyopia. Beyond its clinical practice, AGEI is a leading site for ophthalmic clinical trials, partnering with major pharmaceutical and medical device companies to evaluate new treatments for glaucoma, dry eye, and retinal diseases. The center is distinguished by its use of state-of-the-art diagnostic technology and its contribution to the development of surgical protocols used globally. Led by Dr. Kerry Assil and Dr. Avni Gaur, the institute remains at the forefront of surgical innovation in eye care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Assil Eye Institute.